ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

13.36
-0.55
(-3.95%)
Closed 02 February 8:00AM
13.36
0.00
(0.00%)
After Hours: 11:46AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
13.36
Bid
-
Offer
-
Volume
1,616,451
12.93 Day's Range 14.61
5.26 52 Week Range 64.40
Market Cap
Previous Close
13.91
Open
14.08
Last Trade Time
Financial Volume
US$ 22,336,723
VWAP
13.8184
Average Volume (3m)
1,415,505
Shares Outstanding
57,478,905
Dividend Yield
-
PE Ratio
-0.86
Earnings Per Share (EPS)
-15.53
Revenue
251.46M
Net Profit
-892.87M

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was US$13.91. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.26 to US$ 64.40.

Ginkgo Bioworks currently has 57,478,905 shares in issue. The market capitalisation of Ginkgo Bioworks is US$799.53 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.86.

Ginkgo Bioworks (DNA) Options Flow Summary

Overall Flow

Bullish

Net Premium

70k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

DNA Latest News

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) PR Newswire BOSTON, Jan. 23...

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors PR Newswire BOSTON, Jan. 13, 2025 Collaboration...

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 9, 2025 BOSTON, Jan. 9, 2025 /PRNewswire/ --Β Ginkgo Bioworks (NYSE: DNA...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.074906367041213.3514.439911.3501117634112.76089847CS
43.209531.619132062510.150514.43998.44131919911.25902559CS
125.01608.3514.43996.0114155059.67697058CS
26-1.256-8.5933223864314.61616.3925.26673410410.80365345CS
52-37.04-73.492063492150.464.45.262481599625.81807338CS
156-186.64-93.32200255.25.262289905868.02769356CS
260-436.24-97.0284697509449.6634.565.262143901884.24132264CS

DNA - Frequently Asked Questions (FAQ)

What is the current Ginkgo Bioworks share price?
The current share price of Ginkgo Bioworks is US$ 13.36
How many Ginkgo Bioworks shares are in issue?
Ginkgo Bioworks has 57,478,905 shares in issue
What is the market cap of Ginkgo Bioworks?
The market capitalisation of Ginkgo Bioworks is USD 799.53M
What is the 1 year trading range for Ginkgo Bioworks share price?
Ginkgo Bioworks has traded in the range of US$ 5.26 to US$ 64.40 during the past year
What is the PE ratio of Ginkgo Bioworks?
The price to earnings ratio of Ginkgo Bioworks is -0.86
What is the cash to sales ratio of Ginkgo Bioworks?
The cash to sales ratio of Ginkgo Bioworks is 3.05
What is the reporting currency for Ginkgo Bioworks?
Ginkgo Bioworks reports financial results in USD
What is the latest annual turnover for Ginkgo Bioworks?
The latest annual turnover of Ginkgo Bioworks is USD 251.46M
What is the latest annual profit for Ginkgo Bioworks?
The latest annual profit of Ginkgo Bioworks is USD -892.87M
What is the registered address of Ginkgo Bioworks?
The registered address for Ginkgo Bioworks is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ginkgo Bioworks website address?
The website address for Ginkgo Bioworks is www.ginkgobioworks.com
Which industry sector does Ginkgo Bioworks operate in?
Ginkgo Bioworks operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MBIMBIA Inc
US$ 7.11
(15.42%)
2.37M
ALURAllurion Technologies Inc
US$ 6.07
(13.46%)
581.31k
SESSES AI Corporation
US$ 1.19
(13.33%)
25.04M
ENFYEnlightify Inc
US$ 1.36
(12.40%)
95.7k
LITBLightInTheBox Holding Co Ltd
US$ 1.155
(12.14%)
17.6k
DECKDeckers Outdoor
US$ 177.46
(-20.46%)
15.04M
BZHBeazer Homes USA Inc New
US$ 22.18
(-19.93%)
2.11M
VSTSVestis Corporation
US$ 14.00
(-11.62%)
6.16M
KOREKORE Group Holdings Inc
US$ 2.29
(-9.13%)
36.39k
NOVASunnova Energy International Inc
US$ 2.565
(-9.04%)
14.63M
FFord Motor Company
US$ 10.08
(-0.79%)
103.95M
QBTSD Wave Quantum Inc
US$ 5.94
(5.32%)
74.97M
BBDBanco Bradesco SA
US$ 2.12
(0.47%)
55.74M
NUNu Holdings Ltd
US$ 13.25
(-1.41%)
47.85M
VZVerizon Communications Inc
US$ 39.39
(-0.20%)
44.69M

DNA Discussion

View Posts
ItsMyOption ItsMyOption 3 weeks ago
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
DNA under $10
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 1 month ago
cheap
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
DNA under $10
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
DNA 10 day hourly post reverse split
πŸ‘οΈ0
hwang_jini hwang_jini 5 months ago
Cascade (Gates) top holder
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
DNA new. 52 w eek low
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
DNA new 52/week low
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
DNA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
DNA new 52 week low
πŸ‘οΈ0
ItsMyOption ItsMyOption 5 months ago
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 5 months ago
DNA new 52 low
πŸ‘οΈ0
Dingbatt Dingbatt 5 months ago
Interesting stock bought a few for tracking
To see what the crawdads do
πŸ‘οΈ0
ItsMyOption ItsMyOption 6 months ago
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the β€œOfficer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
πŸ‘οΈ0
hwang_jini hwang_jini 6 months ago
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 7 months ago
😂😂😂😂😂😂😂
πŸ‘οΈ0
trade2brich trade2brich 7 months ago
ARK dumped all holdings. I am out. Cut my losses.
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
It will reverse split because there is no choice
πŸ‘οΈ0
JohnnyBlaze JohnnyBlaze 7 months ago
Average down or cut losses?
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
DNA new 52 week low
πŸ‘οΈ0
Acme Investments Acme Investments 7 months ago
Timber!!
πŸ‘οΈ0
JohnnyBlaze JohnnyBlaze 8 months ago
Bought a few
πŸ‘οΈ0
Acme Investments Acme Investments 8 months ago
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 8 months ago
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
DNA new 52 week low
πŸ‘οΈ0
Stump Jumper Stump Jumper 8 months ago
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
πŸ‘οΈ0
philaya philaya 8 months ago
Got in low...
Bounce ready.
πŸ‘οΈ0
ItsMyOption ItsMyOption 8 months ago
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
πŸ‘οΈ0
Stump Jumper Stump Jumper 8 months ago
Is this the bottom?
πŸ‘οΈ0
Acme Investments Acme Investments 8 months ago
Acknowledge Me!! Lol 😂
πŸ‘οΈ0
wiredawg wiredawg 8 months ago
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
DNA new 52 week low
πŸ‘οΈ0
Acme Investments Acme Investments 8 months ago
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
πŸ‘οΈ0
Acme Investments Acme Investments 9 months ago
Still happy??
πŸ‘οΈ0
ItsMyOption ItsMyOption 9 months ago
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
πŸ‘οΈ0
Acme Investments Acme Investments 9 months ago
Hope you took profits!! They just wanted to burn the shorts!!
πŸ‘οΈ0
Acme Investments Acme Investments 9 months ago
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
πŸ‘οΈ0
trade2brich trade2brich 9 months ago
Bought at .70….up 30%
πŸ‘οΈ0
Acme Investments Acme Investments 9 months ago
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
πŸ‘οΈ0
trade2brich trade2brich 9 months ago
ARK bought 12 million shares on Friday
πŸ‘οΈ0
Acme Investments Acme Investments 9 months ago
Ark is like the cattle whisperer!! Slaughter awaits!!
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
DNA new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
Aren’t you the smart one

πŸ‘οΈ0
trade2brich trade2brich 9 months ago
I did not I keep buying
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
No, you buy
New 52 week lo
πŸ‘οΈ0
trade2brich trade2brich 10 months ago
Buy
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
DNA new 52 lo

πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock